TrialPsychopharmacology2011

Dipyridamole monotherapy in schizophrenia: pilot of a novel treatment approach by modulation of purinergic signaling.

Ikwunga Wonodi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.